DK114964B - Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf.Info
- Publication number
- DK114964B DK114964B DK234964AA DK234964A DK114964B DK 114964 B DK114964 B DK 114964B DK 234964A A DK234964A A DK 234964AA DK 234964 A DK234964 A DK 234964A DK 114964 B DK114964 B DK 114964B
- Authority
- DK
- Denmark
- Prior art keywords
- naphthylacetamides
- substituted
- preparation
- acid addition
- addition salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB19159/63A GB1037013A (en) | 1963-05-14 | 1963-05-14 | Naphthylacetamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK114964B true DK114964B (da) | 1969-08-25 |
Family
ID=10124749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK234964AA DK114964B (da) | 1963-05-14 | 1964-05-11 | Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3344146A (xx) |
| AT (1) | AT247867B (xx) |
| BE (1) | BE647591A (xx) |
| BR (1) | BR6459108D0 (xx) |
| CH (1) | CH442340A (xx) |
| DE (1) | DE1493851A1 (xx) |
| DK (1) | DK114964B (xx) |
| ES (1) | ES299783A1 (xx) |
| FI (1) | FI42534B (xx) |
| FR (1) | FR3822M (xx) |
| GB (1) | GB1037013A (xx) |
| NL (2) | NL6405327A (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107205A (en) * | 1977-03-11 | 1978-08-15 | G. D. Searle & Co. | α-Aryl-α,α-bis[ω-(disubstituted amino)alkyl]acetamides and related compounds |
| US4217306A (en) * | 1978-05-01 | 1980-08-12 | G. D. Searle & Co. | α-Aryl-α,α-bis[ω-(disubstituted amino)alkyl]-acetamides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB796839A (en) * | 1955-06-23 | 1958-06-18 | Pharmacia Ab | N,n-disubstituted amides of aryl acetic acids |
-
0
- NL NL124729D patent/NL124729C/xx active
-
1963
- 1963-05-14 GB GB19159/63A patent/GB1037013A/en not_active Expired
-
1964
- 1964-05-04 US US364792A patent/US3344146A/en not_active Expired - Lifetime
- 1964-05-06 BE BE647591D patent/BE647591A/xx unknown
- 1964-05-11 FI FI1005/64A patent/FI42534B/fi active
- 1964-05-11 AT AT412164A patent/AT247867B/de active
- 1964-05-11 DK DK234964AA patent/DK114964B/da unknown
- 1964-05-12 FR FR974149A patent/FR3822M/fr active Active
- 1964-05-12 CH CH616164A patent/CH442340A/de unknown
- 1964-05-12 BR BR159108/64A patent/BR6459108D0/pt unknown
- 1964-05-13 ES ES299783A patent/ES299783A1/es not_active Expired
- 1964-05-13 NL NL6405327A patent/NL6405327A/xx unknown
- 1964-05-14 DE DE19641493851 patent/DE1493851A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES299783A1 (es) | 1964-09-01 |
| BE647591A (xx) | 1964-11-06 |
| FR3822M (fr) | 1966-01-10 |
| GB1037013A (en) | 1966-07-20 |
| BR6459108D0 (pt) | 1973-08-09 |
| NL124729C (xx) | |
| AT247867B (de) | 1966-06-27 |
| NL6405327A (xx) | 1964-11-16 |
| FI42534B (xx) | 1970-06-01 |
| US3344146A (en) | 1967-09-26 |
| DE1493851A1 (de) | 1972-04-13 |
| CH442340A (de) | 1967-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK125421B (da) | Analogifremgangsmåde til fremstilling af 5-substituerede-aza-dibenzo-cycloheptener eller syreadditionssalte deraf. | |
| DK108972C (da) | Fremgangsmåde til fremstilling af lipoylpyridoxamin eller syreadditionssalte deraf. | |
| DK122662B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf. | |
| DK106797C (da) | Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxazol eller syreadditionssalte deraf. | |
| DK133372B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf. | |
| DK134222B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme aminer eller syreadditionssalte deraf. | |
| DK127599B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 2,4-diaminosubstituerede quinazolin-forbindelser eller syreadditionssalte heraf. | |
| DK120493B (da) | Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf. | |
| DK107357C (da) | Fremgangsmåde til fremstilling af basiske estere eller syreadditionssalte deraf. | |
| DK119659B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme estere eller syreadditionssalte deraf. | |
| DK131988B (da) | Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 1-aryloxy-2-hydroxy-3-isopropylamino-propaner eller syreadditionssalte heraf. | |
| DK125701B (da) | Analogifremgangsmåde til fremstilling af N-monosubstituerede 1-aminoindaner eller syreadditionssalte deraf. | |
| DK114207B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme phenylalaninderivater eller syreadditionssalte deraf. | |
| DK103831C (da) | Fremgangsmåde til fremstilling af 4-azathioxanthenderivater eller syreadditionssalte deraf. | |
| DK115842B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. | |
| DK114964B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf. | |
| DK108394C (da) | Fremgangsmåde til fremstilling af substituerede imidazo- eller pyrimido-quinazoliner eller syreadditionssalte deraf. | |
| DK114624B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive, substituerede quinoliziner eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK108973C (da) | Fremgangsmåde til fremstilling af kinolinforbindelser eller syreadditionssaltene deraf. | |
| DK112658B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 1-acyl-substituerede quinolizinforbindelser eller syreadditionssalte deraf. | |
| DK105649C (da) | Fremgangsmåde til fremstilling af 2-dimethylaminopyrazin eller syreadditionssalte deraf. | |
| DK111893B (da) | Fremgangsmåde til fremstilling af substituerede methylhydraziner eller syreadditionssalte deraf. | |
| DK122227B (da) | Fremgangsmåde til fremstilling af 3-sulfamyl-4-halogen-benzamider eller syreadditionssalte heref. | |
| DK114832B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 3β-hydroxy-16α-alkyl-δ<4>-pregnenderivater eller estere deraf. | |
| DK107098C (da) | Fremgangsmåde til fremstilling af 5-hydrazino-pyrazol-derivater eller syreadditionssalte deraf. |